Quinn Opportunity Partners LLC Adverum Biotechnologies, Inc. Transaction History

Quinn Opportunity Partners LLC

  • $939 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.54 - $10.3 $215,080 - $4.1 Million
398,298 New
398,298 $231,000
Q3 2022

Nov 14, 2022
SELL
$0.96 - $9.68 $81,317 - $819,954
-84,706 Reduced 16.84%
418,298 $397,000
Q4 2021

Feb 14, 2022
BUY
$1.74 - $2.4 $443,700 - $612,000
255,000 Added 102.82%
503,004 $885,000
Q2 2021

Aug 16, 2021
BUY
$3.36 - $10.56 $833,293 - $2.62 Million
248,004 New
248,004 $868,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $681M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Quinn Opportunity Partners LLC Portfolio

Follow Quinn Opportunity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quinn Opportunity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email